FDA approval and clinical evidence Tesamorelin carries FDA approval under the brand name Egrifta, specifically for reducing excess visceral abdominal fat in HIV-positive patients with lipodystrophy
What happens if I cannot tolerate the accelerated schedule
Islet transplantation can effectively control blood sugar and prevent long-term complications by increasing the number of islet cells in patients, to reduce their dependence on exogenous insulin and rebuild their physiological regulation of blood sugar (Rickels and Robertson, 2019)
Preference for less frequent injections (weekly versus daily)
Together they produce amplified, pulsatile GH secretion while preserving physiological feedback
Research Citations Bajpai, A., & Bajpai, A